Summary The extent of lectin binding by three human melanoma (LOX, FEMX-I and SESX) and two sarcoma lines (MHMX and OHSX) was related to their potential for experimental metastasis formation in athymic nude mice. The Helix pomatia agglutinin (HPA), which recognises the N-acetyl-D-galactosamine ligand, showed differential binding to the cell lines in a manner that correlated with their ability to give lung colonies after i.v. injection in the mice (P<0.005). The degree of HPA binding and lung colony formation of the cell lines studied was ranked in the following order, LOX> MHMX> OHSX> SESX > FEMX-I. Similar patterns were not observed with the other lectins used in this study (WGA, Con A, PNA and UEA-I). The high HPA reacting LOX melanoma line shows extensive pulmonary metastatic formation with no extrapulmonary colonies, whereas the low HPA reacting FEMX-I cells give only extrapulmonary metastases with no detectable colonies in the lungs. Precoating of tumour cells with HPA prior to injection did not reduce the ability of cells to give pulmonary metastases, suggesting that the HPA epitope was not functionally associated with the pulmonary metastatic potential observed in nude mice. These findings support recent human studies of a correlation between HPA binding and incidence of metastasis, however, our data indicate that there is no causal relationship. Further analyses are required to identify the specific HPA-binding glycoconjugates that may be involved.
Cancer cells often display aberrant glycosylation of surface membrane proteins and lipids (Hakomori & Kannagi, 1983; Reading & Hutchins, 1985) . The altered structure or expression of these sugar-containing molecules on malignant cells is thought to be important for some of the events leading to the formation of metastasis (Nicolson, 1984) , e.g. for binding the cells to receptors expressed in endothelium, basal membranes or extracellular matrices, thereby facilitating the arrest and extravasation of the tumour cells.
Lectins, because of their binding specificity for carbohydrate structures, have been used in many studies to investigate glycoconjugate changes in malignant tissues. Although their usefulness in these type of studies is limited (Rye et al., 1993) since t4ey invariably detect a wide range of individual carbohydrate-containing structures, a number of human studies have demonstrated altered lectin-binding profiles in some malignancies. In particular the N-acetyl-D-galactosamine-binding lectins (e.g. Helix pomatia agglutinin or HPA) have been correlated with poor prognosis and metastatic development in patients with malignant disease of the bladder (Nishiyama et al., 1987) , breast (Leathem & Brooks, 1987; Springer, 1989; Brooks & Leathem, 1991; Fukutomi et al., 1991; Schumacher et al., 1992) , gastrointestinal tract (Kakeji et al., 1991) and prostate (Shiraishi et al., 1992) . Most experimental studies on the role of membrane glyconjugates in the metastatic process have been performed in syngeneic rodent tumour systems (Tao & Burger, 1977; Dennis et al., 1981; Finne et al., 1989; Hagmar et al., 1990) . In the present study we have used human melanoma and sarcoma cell lines in nude mice to examine whether a relationship between lectin binding and metastatic potential could be detected.
Materials and methods

Animals
Congenitally nude mice (Balb/c) were bred and maintained as previously described (Fodstad et al., 1988a) . Animals (4-6 weeks of age) of both sexes were used. (Fodstad et al., 1988a) and SESX malignant melanomas, the OHSX osteogenic sarcoma (Fodstad et al., 1986 ) and the MHMX unclassified sarcoma. The cell lines were all established from biopsies of patients at the Norwegian Radium Hospital. The cells were cultured as monolayers and as xenografts in nude mice. The monolayer cultures were maintained at 37°C in RPMI-1640 medium (Gibco, Paisley, UK) supplemented with 10% fetal calf serum (Serva, Heidelberg, Germany), 1,000 IU ml-' penicillin, 1I00 lg ml-' streptomycin and 2 mg I' L-glutamine. The cells were subcultured twice weekly by detachment with 0.01 M EDTA in calcium-and magnesium-free phosphatebuffered saline (PBS), and routinely checked with Hoechst 33258 (Sigma, St Louis, MO, USA) staining for Mycoplasma infection (Chen, 1977) . In nude mice, tumours were serially transplanted either as s.c. xenografts or as ascitic tumours (FEMX-I) . The identity of all cell lines was verified by DNA fingerprinting.
Experimental metastasis formation Single-cell suspensions of the MHMX, OHSX and SESX cell lines were prepared from s.c. xenografts in nude mice as previously described (Fodstad et al., 1984) . FEMX-I cell lines were obtained from ascitic cultures in nude mice (Fodstad et al., 1988a (Fodstad et al., 1988a) .
As estimated by trypan blue exclusion, the cell viability was always more than 90% for the monolayer cells and more than 50% for those from xenografts. Nude mice were given lateral tail vein injections of 1 x 106 (LOX, FEMX-I, SESX, OHSX) or 2.5-5 x 105 (MHMX) viable cells in 0.2 ml of RPMI. The animals were checked daily for up to 3 months. Animals with clear signs of metastatic disease were sacrificed by a lethal dose of halothane/nitrous oxide and the time from the day of tumour cell injection was recorded. 
Binding of labelled lectins
The following lectins (Sigma) were used: PNA (Arachis Hypogaea), Con A (Canavalia ensiformis), WGA (Triticum vulgaris), HPA (Helix pomatia) and UEA I (Ulex europaeus). The lectins were labelled with 125I by the lodo-Gen method (Fraker & Speck, 1978) , and separated from free radioiodine by gel filtration on Sephadex G25 (Pharmacia, Uppsala, Sweden). The specific activity ranged from 10 to 30 gLCi tLg-' in different preparations. Approximately 10 ng of labelled lectin was added to 1 x 105 viable EDTA-detached monolayer cells (MHMX, SESX, LOX and OHSX) or freshly harvested ascites cells (FEMX-I) suspended in 1 ml of RPMI medium supplemented with 1 mg ml-' bovine serum albumin and incubated for 2 h at 4°C. The cells were pelleted, and after washing three times the cell-associated radioactivity was determined in a gamma counter. The amount of cell-associated radiolabelled lectin was expressed as a percentage of the total radioactivity added.
Pretreatment of LOX tumour cells with HPA Since it has previously been shown that HPA has no toxic or mitogenic effects on cells (Dillner et al., 1975) , we were able to block the HPA binding sites directly with the lectin. LOX cells were preincubated on ice with HPA (10,g ml-') under serum-free conditions for 1 h. In separate groups of nude mice, HPA-treated and control cells (5 x 105 cells) were injected s.c. or i.v. The growth curves of the developing s.c. tumours were constructed as previously described (Fodstad et al., 1980) , and the development of lung colonies after i.v. injection was followed by looking for signs of respiratory distress.
Lectin histochemistry Histochemistry with peroxidase-labelled lectins was performed as previously described (Rye et al., 1993) . In brief, cytospin preparations of EDTA-detached cells from in vitro cultures and from ascites tumours in mice (FEMX-I line only) were fixed in 'dry' acetone for 10 min at room temperature. Slides were incubated with 10 jig ml-' biotinylated lectin for 60 min at room temperature, followed by detection with streptavidin-biotin-peroxidase (Vectastain ABC Kit, Vector). Peroxidase was localised using diaminobenzidine hydrogen peroxide. Parallel sections for controls were incubated with the appropriate inhibitory saccharide.
Statistical analysis
The correlation coefficient (r) was calculated on the extent of lectin binding in the cell lines and metastases formation. The significance of the nil correlation was confirmed using the t-test at three degrees of freedom.
Results
Binding of radioiodinated lectins to tumour cells The '251-labelled lectins bound, at saturating concentrations, to the tumour cell lines, as shown in Table I . With HPA a 100-fold difference was seen in the amount of labelled lectin bound to the cell line with the highest (LOX) and the lowest (FEMX-I) binding level. The LOX and the MHMX cells bound 45% and 25% of the added amount of HPA lectin, while the value for the OHSX cells was 1.6% and for the SESX and FEMX-I cells only 0.8% and 0.4% respectively. The five cell lines bound about equal amounts of WGA, whereas the binding of Con A differed about 3-fold between the different cell lines (Table 1 ). All the lines bound very low amounts of labelled UEA-I and PNA, with a 4-fold variation in binding levels.
The amount of labelled lectin bound to the cells (Table I) 
Experimental metastasis formation
We have previously reported on the metastasis patterns of LOX and FEMX-I melanoma cells injected i.v. in nude mice. The LOX cell line gives lung colonies (Fodstad et al., 1988b) , while the FEMX-I cells give adrenal, subcutaneous and brown fat metastases (Fodstad et al., 1988a (Figure 2 ). The development of extrapulmonary metastases in mice showed no relationship to lectin receptor levels in any of the cell lines tested.
Blocking of HPA receptors Given the observed correlation between the HPA-binding phenotype and lung colony formation in nude mice, the pretreatment of tumour cells prior to injection was restricted to the LOX melanoma line: cells preincubated with HPA immediately before i.v. injection in nude mice showed the same latency period and organ involvement as control cells. Thus, the six mice that received 5 x 105 HPA-treated LOX cells lived for 33.5 ± 6.0 days, and the six control animals for 32.0 ± 5.0 days.
In order to determine that the HPA receptors remained inaccessible during the course of the experiment, LOX cells were initially saturated with HPA and subsequently incubated in vitro for 150 min in serum-containing medium at 37°C in the absence of HPA. The cells did not regain their ability to bind 125I-labelled HPA (data not shown).
Preincubation of the LOX tumour cells with HPA (10,ugml-') did not reduce subsequent protein synthesis or cell proliferation in vitro, and the growth properties of the treated LOX cells injected s.c. in both flanks of five nude mice were also unaffected (data not shown).
Discussion
This study has shown that the cellular expression of N-acetyl-D-galactosamine-containing glycoconjugates as detected by HPA shows a correlation with pulmonary metastases in athymic nude mice. It would appear from the results that the HPA ligand is not directly involved in the formation of pulmonary metastases. However, one or more of the glycoconjugates expressing the HPA ligand may conceivably be involved in this site-specific metastasis.
In other experimental rodent tumour systems correlations have been observed between the metastatic properties of tumour cells and their ability to bind different lectins (Reading et al., 1990; Dennis et al., 1981; Buckley & Carlson, 1988; Finne et al., 1989) . Moreover, a similar relationship has been shown for a human melanoma cell line injected i.v. into nude mice (Ishikawa & Kerbel, 1989) . Lack of correlation between metastatic capacity and N-acetyl-D-galactosaminebinding lectins (e.g. Glycine max agglutinin or SBA) has previously been reported for some rodent tumours. Altevogt et al. (1983) found that low-metastatic cell lines had large amounts of SBA receptors, and that the inverse was true for metastatic cells. In other studies (Buckley & Carlsen, 1988) , it was found that the binding of SBA did not correlate with the appearance of experimental Ixung metastasis, whereas an apparent association seemed to exist for the formation of lymph node metastasis. In contrast to the latter observations, our human FEMX-I cells, which predominantly form lymph node metastases after i.v. injection into nude mice (Fodstad et al., 1988a) , were found to have small amounts of HPA and SBA receptors. A lack of correlation with HPA binding has also been observed in some human studies (Galea et al., 1991; Taylor et al., 1991) . The apparent contradictions and absence of correlation in some studies may be a result of quantitative differences in receptor/ligand expression in the metastatic cell and/or host tissues (Pauli et al., 1990) . These studies also highlight the difficulties of using lectins to identify individual glycoconjugates associated with specific functions (Rye et al., 1993; Walker, 1993) . Our findings with the other lectins WGA, Con A, PNA and UEA-I support the cautionary note on the use of lectins in this type of study (Rye et al., 1993 to determine which HPA-binding glycoconjugate(s) are involved in this metastatic cell behaviour. The study of metastasis mechanisms involves several inherent difficulties. Thus, the end point in vivo is the appearance of manifest metastatic foci, the development of which is influenced by a multitude of tumour cell-and hostassociated factors. Injecting the tumour cells by the i.v. route limits the number of factors involved, but unfortunately it also reduces the similarity of the models to the situation in patients. In support of the biological relevance of the distinct tissue-preferenced growth seen in the present experiments, we have with LOX and FEMX-I cells observed similar tissuepreferenced metastasis development also after injection of the tumour cells either intrasplenic, i.p. or in the footpad of mice (Fodstad et al., 1988a) . In the same study we also showed that trypsinisation of the LOX cells before i.v. injection reduces their potential for forming lung colonies in the recipient animals. That this could have an effect on the HPA receptor was excluded in the present study, as trypsin treatment of intact cells did not alter the ability of LOX cells to bind HPA (data not shown).
In spite of the limitations of the experimental metastasis model used in this study, the data obtained are supported by studies in other model systems and in humans. Although it is inappropriate to make generalisations regarding cell characteristics involved in a complex process such as metastasis formation on the basis of correlations observed in one model system, our findings do support the recent retrospective studies in human cancers (Leathem & Brooks, 1987; Nishiyama et al., 1987; Springer, 1989; Brooks & Leathem, 1991; Fukutomi et al., 1991; Kakeji et al., 1991; Schumacher et al., 1992; Shiraishi et al., 1992) implicating a role for HPA-binding glycoconjugates in site-specific metastasis development.
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